From Cholesterol to Breast Cancer

  • Author: Melania Tesio
  • Published: 20 December 2013
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
  • Source / Publisher: Science/American Association for the Advancement of Science (AAAS)
thumbnail image: From Cholesterol to Breast Cancer

Cholesterol is a fat molecule that causes heart attacks and strokes when it accumulates in arteries in excessive amounts. According to Eric Nelson, Duke University School of Medicine, Durham, NC, USA, and colleagues, the detrimental role of this lipid is not limited to the cardiovascular system.


The researchers demonstrated that cholesterol metabolites sustain the growth of hormone-dependent breast cancer cells. On the surface of these cells are receptors for estrogens, female steroid hormones, and the proliferation of these cancer cells depends on the signals delivered by these molecules. When estrogens are not available, however, breast cancer cells convert cholesterol into 27-hydroxycholesterol (27HC), a metabolite that mimics estrogens, thereby driving tumoral growth.

These findings explain the reason why elevated blood cholesterol levels are associated with a high risk of developing breast cancer, thus suggesting that cholesterol-lowering drugs, such as statins or compounds inhibiting cholesterol conversion into 27HC, may help to prevent or treat breast cancers.


Article Views: 2458

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more


CONNECT:

ChemistryViews.org on Facebook

ChemistryViews.org on Twitter ChemistryViews.org on YouTube ChemistryViews.org on LinkedIn Sign up for our free newsletter


A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH